Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Council Votes topic
No spam. Unsubscribe anytime.
Votes at a glance: Hialeah council approves appointments, zoning and a fluoride resolution; several items set for May 13
Summary
Council approved multiple motions in a single meeting: a board appointment, a county‑fluoride support resolution, multiple zoning items and first readings. One pharmaceutical research permit was tabled. Second readings and public hearings were scheduled for May 13, 2025 where required.
Get email alerts on the Council Votes topic
No spam. Unsubscribe anytime.
The Hialeah City Council took a series of formal actions at the meeting, approving an appointment, voting on a county fluoride resolution, adopting multiple zoning motions and scheduling several second‑reading public hearings. The meeting also postponed a special‑use request for a pharmaceutical research center.
Key outcomes
- Alejandra Cortina — Beautification Committee appointment: Motion by Tundidor; second by Zogby. Roll call: Tunidor (yes), Zogby (yes), Junco (yes), Garcia Robez (yes), de la Vega (yes), Perez (yes), Rodriguez (yes). Outcome: approved.
- City resolution supporting Miami‑Dade County resolution R‑370‑25 (remove fluoride from county water): Motion by Commissioner Roberto J. González was acknowledged; Council motion to affirm support by Antonio, second by Rodriguez. Roll call recorded unanimous yes votes and the item was approved; council instructed the mayor or designee to advocate for removal of fluoride as described in the resolution. (Text in agenda: direct Miami‑Dade Water and Sewer Department to discontinue adding fluoride, not later than 30 days.)
- Consent agenda: Passed as presented except item K (fluoride resolution) was pulled for separate consideration and later approved.
- Historic Preservation Board ordinance (first reading): Council approved first reading to amend code language affecting historic preservation board appointment rules; second reading and public hearing scheduled for May 13, 2025.
- Neighborhood Business District mixed affordable housing (11b): Approved on first reading (see separate article for details); second reading scheduled for May 13, 2025.
- Conditional use and zoning approvals (selected items that passed on second reading or were approved for first reading): • Conditional use to allow an elementary school within a 950‑sq‑ft bay and day‑care expansion at 6815–6895 W. 4th Ave: approved on second reading (roll call recorded yes votes by Perez, Rodriguez, Tunidor, Zogby, Junco, Garcia Robez, de la Vega). Outcome: approved. • Rezoning and conditional use at 106 W. 9th St. to allow a K–3 elementary school and day care, plus variances for parking and pervious area: approved on second reading. Outcome: approved. • Expansion of an existing K–12 school at 3751 W. 100th St. (first reading): approved; second reading scheduled for May 13, 2025. • Reapproval of a previously revoked project at 65 W. 7th St. (first reading, same project previously approved in 2023 and revoked for missing building plans): approved on first reading; second reading scheduled May 13, 2025. • Mixed‑use conversion (partial retrofit) at Lago Plaza, 2750 W. 68th St.: first reading approved to convert the vacant second floor to up to 33 live‑work lofts in conjunction with the existing shopping center; second reading scheduled for May 13, 2025.
- Pharmaceutical research center at 3412 W. 84th St., Suite 102: Council voted to table the item to the May 13, 2025 meeting to allow applicant representation to appear and answer questions.
Why it matters: the actions advance several land‑use projects and a local policy stance on county water fluoridation. Multiple items will return at a May 13 public hearing before becoming final ordinances.
Speakers and attribution: Motions and roll calls were recorded on the public record; votes quoted in this roundup reflect roll‑call statements captured in the meeting transcript. Specific mover/second names are listed where recorded.
Ending: Second readings and public hearings for multiple items are scheduled for the May 13, 2025 council meeting; the pharmaceutical research application remains open pending applicant testimony.

